Thursday, May 04, 2017 10:24:12 PM
Analysts expect ImmunoVaccine Inc. (TSX:IMV) to report $-0.02 EPS on May, 9.They anticipate $0.00 EPS change or 0.00% from last quarter’s $-0.02 EPS. After having $-0.03 EPS previously, ImmunoVaccine Inc.’s analysts see -33.33% EPS growth. It is down 109.09% since September 27, 2016 and is uptrending. It has outperformed by 98.53% the S&P500.
FEATURED Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • Mar 16, 2026 8:37 AM
Record Gold Prices Reshape Economics of New Mine Development • KGC • Mar 16, 2026 9:00 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
